Cellectis (CLLS) Short Interest Ratio & Short Volume → AI Hell Will Break Loose [June 30, 2024] … (From Banyan Hill Publishing) (Ad) Free CLLS Stock Alerts $2.67 -0.06 (-2.20%) (As of 06/6/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Cellectis Short Interest DataCurrent Short Interest509,900 sharesPrevious Short Interest656,100 sharesChange Vs. Previous Month-22.28%Dollar Volume Sold Short$1.57 millionShort Interest Ratio9.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares55,580,000 sharesPercentage of Shares Shorted0.92%Today's Trading Volume10,018 sharesAverage Trading Volume31,765 sharesToday's Volume Vs. Average32% Short Selling Cellectis ? Sign up to receive the latest short interest report for Cellectis and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLLS Short Interest Over TimeCLLS Days to Cover Over TimeCLLS Percentage of Float Shorted Over Time Ad Oasis GoldThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency.Act now and claim your free information kit before it's too late! Cellectis Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024509,900 shares $1.57 million -22.3%N/A9.9 $3.08 4/30/2024656,100 shares $1.68 million -2.5%N/A12.9 $2.56 4/15/2024672,800 shares $1.76 million -0.6%N/A17.8 $2.62 3/31/2024676,500 shares $1.79 million -0.4%N/A16.3 $2.65 3/15/2024679,300 shares $1.73 million -6.6%N/A13.5 $2.54 2/29/2024727,500 shares $1.88 million -0.1%N/A10.6 $2.58 Get the Latest News and Ratings for CLLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectis and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024728,200 shares $2.08 million -0.9%N/A8.2 $2.85 1/31/2024735,100 shares $2.21 million -4.2%N/A3.6 $3.00 1/15/2024767,300 shares $2.22 million -1.9%N/A0.4 $2.89 12/31/2023781,800 shares $2.41 million -7.0%N/A0.4 $3.08 12/15/2023840,900 shares $2.69 million -19.9%N/A0.5 $3.20 11/30/20231,050,000 shares $3.13 million -28.1%N/A0.6 $2.98 11/15/20231,460,000 shares $4.09 million +302.8%N/A0.8 $2.80 10/31/2023362,500 shares $349,450.00 -2.7%N/A0.2 $0.96 10/15/2023372,400 shares $513,912.00 +7.9%N/A6.9 $1.38 9/30/2023345,200 shares $545,416.00 +7.6%N/A5.6 $1.58 9/15/2023320,800 shares $545,360.00 -0.5%N/A6.3 $1.70 8/31/2023322,300 shares $667,161.00 -2.7%N/A6.5 $2.07 8/15/2023331,100 shares $652,267.00 -3.5%N/A6.5 $1.97 7/31/2023343,200 shares $734,448.00 +9.2%N/A5.7 $2.14 7/15/2023314,400 shares $704,287.44 +0.5%N/A5.5 $2.24 6/30/2023312,800 shares $615,434.00 -1.4%N/A6.2 $1.97 6/15/2023317,300 shares $640,946.00 +2.6%N/A5.2 $2.02 5/31/2023309,200 shares $587,480.00 -2.5%N/A4.5 $1.90 5/15/2023317,200 shares $558,272.00 +0.2%N/A4.6 $1.76 4/30/2023316,700 shares $595,396.00 -13.0%N/A3.7 $1.88 4/15/2023363,800 shares $742,152.00 -0.2%N/A3.2 $2.04 3/31/2023364,600 shares $703,678.00 -2.3%N/A2.8 $1.93 3/15/2023373,100 shares $682,773.00 +1.4%N/A2.7 $1.83 2/28/2023367,900 shares $813,059.00 -6.6%N/A2.5 $2.21 2/15/2023393,800 shares $945,120.00 +5.4%N/A2.6 $2.40 1/31/2023373,600 shares $1.14 million +34.6%N/A2.4 $3.05 1/15/2023277,600 shares $1.07 million +31.0%0.6%2.4 $3.84 12/30/2022211,900 shares $444,990.00 -32.2%0.5%1.9 $2.10 12/15/2022312,400 shares $702,900.00 -17.4%0.7%3.2 $2.25 11/30/2022378,000 shares $831,600.00 -28.2%0.8%4.5 $2.20 11/15/2022526,300 shares $1.18 million -9.3%1.2%6.3 $2.25 10/31/2022580,400 shares $1.44 million -13.9%1.3%6.9 $2.49 10/15/2022674,400 shares $1.66 million -6.7%1.5%6.5 $2.46 9/30/2022722,600 shares $1.65 million -11.8%1.6%6.6 $2.29The Scary Fed Idea To Turn Your Dollars Into a Digital Power Grab (Ad)Cash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with their own controllable, traceable, programmable digital currency.Act now and claim your free information kit before it's too late! 9/15/2022819,400 shares $2.61 million -2.4%1.8%7.2 $3.19 8/31/2022839,700 shares $2.78 million -2.4%1.9%6.5 $3.31 8/15/2022860,300 shares $3.51 million -3.0%1.9%6.3 $4.08 7/31/2022887,300 shares $2.32 million -9.2%2.0%6.1 $2.62 7/15/2022976,800 shares $2.40 million +1.0%2.2%6.7 $2.46 6/30/2022966,900 shares $2.74 million -4.3%2.2%6.7 $2.83 6/15/20221,010,000 shares $2.53 million -2.9%2.2%6.7 $2.50 5/31/20221,040,000 shares $3.76 million -1.9%2.3%5.2 $3.62 5/15/20221,060,000 shares $3.36 million -12.4%2.4%4.4 $3.17 4/30/20221,210,000 shares $4.24 million -24.8%2.7%4.7 $3.50 4/15/20221,610,000 shares $6.65 million -5.9%3.6%5.8 $4.13 3/31/20221,710,000 shares $7.76 million -4.5%3.8%5.5 $4.54 3/15/20221,790,000 shares $7.59 million -8.2%4.0%5.8 $4.24 2/28/20221,950,000 shares $8.83 million +18.9%4.3%6.5 $4.53 2/15/20221,640,000 shares $9.18 million +46.4%3.6%6.4 $5.60 1/31/20221,120,000 shares $6.96 million +16.7%2.5%4.6 $6.21 1/15/2022959,700 shares $7.00 million +31.4%N/A4.4 $7.29 12/31/2021730,200 shares $5.93 million +9.4%1.6%3.3 $8.12 12/15/2021667,300 shares $5.61 million -7.7%1.5%2.9 $8.41 11/30/2021722,900 shares $6.23 million +17.9%1.6%3.4 $8.62 11/15/2021613,200 shares $6.12 million +2.6%1.4%3.1 $9.98 10/29/2021597,800 shares $6.43 million -38.0%1.3%3 $10.76 10/15/2021964,500 shares $10.45 million -22.8%2.1%4.9 $10.83 9/30/20211,250,000 shares $15.76 million -1.6%2.8%6.7 $12.61 9/15/20211,270,000 shares $17.78 million +1.6%2.8%7.6 $14.00 8/31/20211,250,000 shares $17.98 million -3.9%2.8%6.7 $14.38 8/13/20211,300,000 shares $16.28 million -7.8%2.9%6.2 $12.52 7/30/20211,410,000 shares $18.26 million No Change3.1%6.5 $12.95 7/15/20211,410,000 shares $19.29 million +11.9%3.1%6.4 $13.68 6/30/20211,260,000 shares $19.49 million +5.9%2.8%5.6 $15.47 6/15/20211,190,000 shares $17.92 million -21.7%2.6%4.5 $15.06 5/28/20211,520,000 shares $23.82 million +2.7%3.4%5.4 $15.67 5/14/20211,480,000 shares $21.93 million +28.7%N/A4.5 $14.82 4/30/20211,150,000 shares $21.76 million -0.9%2.8%3.2 $18.92 4/15/20211,160,000 shares $22.63 million -5.7%2.8%2.9 $19.51 3/31/20211,230,000 shares $23.14 million +10.8%3.2%2.7 $18.81 3/15/20211,110,000 shares $22.14 million +28.1%2.9%2.4 $19.95 2/26/2021866,800 shares $17.89 million +117.8%2.2%1.7 $20.64 2/12/2021398,000 shares $10.70 million -9.3%1.0%0.9 $26.88 1/29/2021438,700 shares $12.39 million -28.6%1.0%1 $28.25 1/15/2021614,200 shares $19.00 million -21.5%1.5%1.7 $30.94 12/31/2020782,100 shares $23.00 million -10.9%1.9%2.3 $29.41 12/15/2020878,100 shares $27.41 million -3.6%2.1%3.1 $31.21 11/30/2020911,200 shares $22.06 million -10.7%2.2%4.6 $24.21 11/15/20201,020,000 shares $19.50 million +20.8%2.4%5.8 $19.12 10/30/2020844,700 shares $13.82 million +16.8%2.0%4.9 $16.36 10/15/2020723,400 shares $15.86 million +28.2%1.7%4.5 $21.92 9/30/2020564,200 shares $10.44 million -0.5%1.3%3.7 $18.50 9/15/2020567,100 shares $11.44 million +4.8%1.3%3.7 $20.18 8/31/2020540,900 shares $9.98 million +18.4%1.3%3.2 $18.45AI Hell Will Break Loose [June 30, 2024] … (Ad)On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before June 30 at the very latest. Watch this now to find out why. 8/14/2020456,800 shares $7.82 million +32.1%1.1%2.4 $17.12 7/31/2020345,700 shares $5.43 million -0.1%0.8%1.6 $15.70 7/15/2020345,900 shares $6.15 million -3.7%0.8%1.6 $17.77 6/30/2020359,300 shares $6.45 million +39.9%0.9%1.7 $17.94 6/15/2020256,900 shares $4.20 million -16.9%0.6%1.2 $16.34 5/29/2020309,200 shares $5.71 million -8.0%0.7%1.6 $18.47 5/15/2020336,000 shares $6.49 million -5.8%0.8%1.9 $19.32 4/30/2020356,700 shares $4.65 million +34.4%0.8%2.4 $13.05 4/15/2020265,400 shares $2.89 million +21.2%0.6%1.8 $10.89 3/31/2020218,900 shares $2.64 million -35.3%0.5%1.6 $12.06 3/13/2020338,500 shares $3.28 million +5.7%0.8%2.6 $9.70 2/28/2020320,200 shares $2.50 million +13.0%0.8%2.3 $7.81 2/14/2020283,300 shares $3.52 million +8.2%0.7%2.2 $12.42 1/31/2020261,800 shares $4.38 million +15.4%0.6%2 $16.74 1/15/2020226,800 shares $4.02 million -7.5%0.5%1.7 $17.71 12/31/2019245,100 shares $4.02 million -22.7%0.6%2 $16.39 CLLS Short Interest - Frequently Asked Questions What is Cellectis' current short interest? Short interest is the volume of Cellectis shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 509,900 shares of CLLS short. Learn More on Cellectis' current short interest. What is a good short interest ratio for Cellectis? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLLS shares currently have a short interest ratio of 10.0. Learn More on Cellectis's short interest ratio. Which institutional investors are shorting Cellectis? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cellectis: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cellectis' short interest increasing or decreasing? Cellectis saw a drop in short interest in May. As of May 15th, there was short interest totaling 509,900 shares, a drop of 22.3% from the previous total of 656,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cellectis' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellectis: Lexeo Therapeutics, Inc. (4.46%), Adaptive Biotechnologies Co. (8.92%), Cabaletta Bio, Inc. (18.85%), Editas Medicine, Inc. (25.24%), Voyager Therapeutics, Inc. (7.98%), Ocugen, Inc. (20.24%), Alector, Inc. (10.33%), TScan Therapeutics, Inc. (0.93%), Fate Therapeutics, Inc. (18.28%), Allogene Therapeutics, Inc. (30.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Cellectis stock? Short selling CLLS is an investing strategy that aims to generate trading profit from Cellectis as its price is falling. CLLS shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectis? A short squeeze for Cellectis occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLLS, which in turn drives the price of the stock up even further. How often is Cellectis' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLLS, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Lexeo Therapeutics Short Interest Adaptive Biotechnologies Short Interest Cabaletta Bio Short Interest Editas Medicine Short Interest Voyager Therapeutics Short Interest Ocugen Short Interest Alector Short Interest TScan Therapeutics Short Interest Fate Therapeutics Short Interest Allogene Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLLS) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the big...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.